Cargando…
Risk Factors Leading to Anti-TNF Alpha Therapies in Pediatric Severe Uveitis
PURPOSE: Pediatric uveitis is the leading cause of acquired child blindness, due to unremitting inflammation and long-term steroid exposition. Biotherapies with anti-tumor necrosis factor alpha (anti-TNFα) are effective in controlling inflammation for severe pediatric uveitis in recent studies. Majo...
Autores principales: | Osswald, Delphine, Rameau, Anne-Cécile, Terzic, Joëlle, Sordet, Christelle, Bourcier, Tristan, Sauer, Arnaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931283/ https://www.ncbi.nlm.nih.gov/pubmed/35311049 http://dx.doi.org/10.3389/fped.2022.802977 |
Ejemplares similares
-
Pediatric uveitis: Role of the pediatrician
por: Shivpuri, Abhay, et al.
Publicado: (2022) -
Response of pediatric uveitis to TNFα inhibitors
por: Lerman, Melissa A, et al.
Publicado: (2012) -
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease
por: Sugita, Sunao, et al.
Publicado: (2012) -
Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease – Data from the multicenter CEDATA-GPGE registry study
por: Claßen, Merle, et al.
Publicado: (2022) -
Immune function in newborns with in-utero exposure to anti-TNFα therapy
por: Weiss, Batia, et al.
Publicado: (2022)